CA2360661A1 - Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections - Google Patents

Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections Download PDF

Info

Publication number
CA2360661A1
CA2360661A1 CA002360661A CA2360661A CA2360661A1 CA 2360661 A1 CA2360661 A1 CA 2360661A1 CA 002360661 A CA002360661 A CA 002360661A CA 2360661 A CA2360661 A CA 2360661A CA 2360661 A1 CA2360661 A1 CA 2360661A1
Authority
CA
Canada
Prior art keywords
substituted
viruses
bacteria
genus
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002360661A
Other languages
English (en)
French (fr)
Inventor
Hassan Jomaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jomaa Pharmaka GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2360661A1 publication Critical patent/CA2360661A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Pest Control & Pesticides (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CA002360661A 1999-01-26 2000-01-25 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections Abandoned CA2360661A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19902924A DE19902924A1 (de) 1999-01-26 1999-01-26 Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen
DE19902924.5 1999-01-26
PCT/EP2000/000542 WO2000044358A2 (de) 1999-01-26 2000-01-25 Verwendung von phosphororganischen verbindungen zur prophylaktischen und therapeutischen behandlung von infektionen

Publications (1)

Publication Number Publication Date
CA2360661A1 true CA2360661A1 (en) 2000-08-03

Family

ID=7895365

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002360661A Abandoned CA2360661A1 (en) 1999-01-26 2000-01-25 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections

Country Status (14)

Country Link
EP (1) EP1146880A2 (no)
JP (1) JP2002535354A (no)
CN (1) CN1337881A (no)
AU (1) AU2439900A (no)
CA (1) CA2360661A1 (no)
CZ (1) CZ20012584A3 (no)
DE (1) DE19902924A1 (no)
HU (1) HUP0105310A3 (no)
IL (1) IL144115A0 (no)
NO (1) NO20013651L (no)
PL (1) PL349910A1 (no)
SK (1) SK10552001A3 (no)
TR (1) TR200102151T2 (no)
WO (1) WO2000044358A2 (no)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9949988B2 (en) 2014-09-12 2018-04-24 Antibiotx A/S Antibacterial use of halogenated salicylanilides
US10463680B2 (en) 2015-05-29 2019-11-05 UNION therapeutics A/S Halogenated salicylanilides for treating clostridium infections
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7842719B2 (en) * 2002-10-31 2010-11-30 Kemin Foods, L.C. Use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis C, bovine viral diarrhea and classical swine fever virus
WO2004085448A2 (en) * 2003-03-19 2004-10-07 Genzyme Corporation Unsaturated phosphinyl-phosphonate phosphate transport inhibitors
JP2012521365A (ja) * 2009-03-20 2012-09-13 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 抗結核剤としてのプレニル化ビスホスホネート
CN104026151A (zh) * 2014-06-19 2014-09-10 南京麦思德餐饮管理有限公司 一种紫花苜蓿浸种剂
CN105403221B (zh) * 2015-10-27 2018-01-23 广东欧珀移动通信有限公司 一种导航路线的生成方法及移动终端

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3170944A (en) * 1962-11-20 1965-02-23 Stauffer Chemical Co Haloacetonyl phosphonates and a method of preparing them
US3372209A (en) * 1964-08-24 1968-03-05 Monsanto Co Diphosphorus ester hydrocarbon diols
BE687874A (no) * 1965-10-06 1967-04-06
US3532774A (en) * 1966-09-29 1970-10-06 Monsanto Co Phosphinites,phosphine oxides and process for preparing
JPS4861259A (no) * 1971-12-02 1973-08-28
US4254114A (en) * 1979-01-02 1981-03-03 The Proctor & Gamble Company Control of pyrophosphate microorganisms with organophosphonates
JPS5655394A (en) * 1979-10-12 1981-05-15 Otsuka Chem Co Ltd 1,2-di alkoxycarbonylmethylamino ethylene-1,2-disulfonic acid phenyl ester derivative, its preparation, and herbicide containing said compound
DE3208600A1 (de) * 1982-03-10 1983-09-22 Henkel KGaA, 4000 Düsseldorf Amidinodiphosphonsaeuren
CH664158A5 (fr) * 1984-07-18 1988-02-15 Symphar Sa Derives propylidenediphosphonates-1,3 substitues en position 2, leur procede de preparation et compositions pharmaceutiques les contenant.
US4820698A (en) * 1985-11-04 1989-04-11 The Procter & Gamble Company Antimicrobial agents and process for their manufacture
US5196409A (en) * 1989-08-20 1993-03-23 Yissum, Research Development Company Of The Hebrew University Of Jerusalem Bisphosphonates, pharmaceutical compositions, and process for the treatment of irregularities in calcium metabolism
DE4336099A1 (de) * 1993-10-22 1995-04-27 Boehringer Mannheim Gmbh Neue 2.4-Diphosphonoglutarsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
WO1996016629A2 (en) * 1994-11-18 1996-06-06 Amira Inc Phosphinic creatine compounds having antiviral activity
DE19532235A1 (de) * 1995-08-31 1997-03-06 Keppler Bernhard K Priv Doz Dr An Phosphonsäuren gekoppelte antibakteriell wirksame Verbindungen zur Therapie von Infektionen im Bereich des Knochens
GB9613637D0 (en) * 1996-06-28 1996-08-28 Agrevo Uk Ltd Fungicidal compositions
EP0944635A4 (en) * 1996-10-09 2000-07-05 Elizanor Biopharmaceuticals In THERAPEUTIC DIPHOSPHONATE COMPOUNDS

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9949988B2 (en) 2014-09-12 2018-04-24 Antibiotx A/S Antibacterial use of halogenated salicylanilides
US10758553B2 (en) 2014-09-12 2020-09-01 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
US11285164B2 (en) 2014-09-12 2022-03-29 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
US11324761B2 (en) 2014-09-12 2022-05-10 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
US11331327B2 (en) 2014-09-12 2022-05-17 UNION therapeutics A/S Antibacterial use of halogenated salicylanilides
US10463680B2 (en) 2015-05-29 2019-11-05 UNION therapeutics A/S Halogenated salicylanilides for treating clostridium infections
US10857164B2 (en) 2015-05-29 2020-12-08 UNION therapeutics A/S Halogenated salicylanilides for treating Clostridium infections
US11529361B2 (en) 2015-05-29 2022-12-20 UNION therapeutics A/S Halogenated salicylanilides for treating Clostridium infections
US11419834B2 (en) 2019-02-25 2022-08-23 Rhode Island Hospital Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide

Also Published As

Publication number Publication date
WO2000044358A3 (de) 2001-03-15
EP1146880A2 (de) 2001-10-24
PL349910A1 (en) 2002-10-07
NO20013651L (no) 2001-09-18
AU2439900A (en) 2000-08-18
HUP0105310A2 (en) 2002-06-29
WO2000044358A2 (de) 2000-08-03
SK10552001A3 (sk) 2001-12-03
DE19902924A1 (de) 2000-08-03
TR200102151T2 (tr) 2002-05-21
HUP0105310A3 (en) 2002-08-28
NO20013651D0 (no) 2001-07-25
CN1337881A (zh) 2002-02-27
CZ20012584A3 (cs) 2002-01-16
JP2002535354A (ja) 2002-10-22
IL144115A0 (en) 2002-05-23

Similar Documents

Publication Publication Date Title
JP2002511406A (ja) 感染症の治療および予防処置のための有機リン化合物の使用
US6812224B2 (en) Phosphorous organic compounds and their use
US6638957B1 (en) Use of compounds with a nitrogen-oxygen heterocycle
US6534489B1 (en) Organophosphorus compounds and the use thereof
CA2360661A1 (en) Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
US20030036533A1 (en) Phosphorous organic compounds and their use
ZA200101912B (en) Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants.
ZA200104443B (en) Organo-phosphorus compounds and their utilization.
US20030144249A1 (en) Use of organophosphorous compounds for producing a medicament for treating infections
CA2352549A1 (en) Use of phosphonoformic acid derivatives for treating infections
WO2000017212A1 (de) Phosphororganische verbindungen und ihre verwendung
AU1859100A (en) Use of phosphonoformic acid derivatives for treating infections
AU2003261554A1 (en) Organophosphorus containing preparations and applications therefor
MXPA01002979A (en) Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants
SK19612000A3 (sk) Kombinovaný prípravok antiinfekčne pôsobiacich zlúčenín, ktoré inhibujú metabolickú dráhu 2-c-metylerytrózy-4 a inhibítorov metabolizmu lipidov
CZ2001989A3 (cs) Použití fosfororganických sloučenin pro výrobu léčiv pro terapeutické a profylaktické ošetřování infekcí nebo jako fungicid, baktericid či herbicid u rostlin
MXPA01000488A (en) Phosphorous organic compounds and their use

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued